November 28, 2021

Acetaminophen (Paracetamol) Market Report Till 2031:

Visiongain has published a new report on Acetaminophen (Paracetamol) Market Report to 2031: Forecast by type (veterinary drug grade and acetaminophen grade), By form (tablet, capsule, liquid suspension and powder), By application (Pharmaceutical, dyeing and chemical industries) PLUS COVID-19 recovery scenarios.

Impact of COVID-19 on the acetaminophen (paracetamol) market
The COVID-19 pandemic has posed an unprecedented health risk. Drugs that can decrease the severity of the infection and decrease the high death rate. To this end, several drugs have been reused, including paracetamol. It can help relieve patients with these symptoms; however, it is not a cure for COVID-19[female[feminine.

Download an exclusive sample report @

Paracetamol made headlines in the initial phase of COVID-19 for the reason that some agencies and government organizations including the World Health Organization, France and the United Kingdom encouraged people with COVID-19[female[feminine take paracetamol instead of ibuprofen. Additionally, the pandemic has increased demand for pharmaceutical drugs but has also disrupted the entire pharmaceutical supply chain. Pharmacies run out of acetaminophen and some stores limit sales of these drugs. However, pharmaceutical companies have dramatically improved their production capacity to keep pace with the growing demand for drugs. In turn, it should have a positive impact on the growth of the target industry.

Market factors

Growing prevalence of chronic disease
The increasing incidence and prevalence of cardiovascular disease, osteoarthritis and multiple cancers is expected to be determining factors for the acetaminophen (paracetamol) market growth during the forecast period. According to estimates from Cancer Australia, around 1,405 new cases of brain cancer are expected in 2017. In addition, according to the World Health Organization (WHO), the common cause of death is cardiovascular disease (CVD) in the world. In addition, according to the Centers for Disease Control and Prevention (CDC), nearly 1.70 million people die of chronic disease each year in the United States. Although chronic disease is the leading cause of death for both men and women, as women face unique health issues. About 37% of women suffer from chronic diseases, compared to 30% of men. In addition, according to estimates by the World Health Organization (WHO), by 2050, around 130 million people are expected to suffer from osteoarthritis worldwide. Thus, the increasing high prevalence of cardiovascular disease and other chronic disorders requires appropriate management of treatment to maximize patient outcomes. In turn, it is expected to achieve substantial growth for the Acetaminophen (Paracetamol) market in the given time frame.

Growing demand for pain management drugs

There is an availability of sophisticated treatments and technological developments that have universally increased lifespan, resulting in an upsurge in the elderly population. Since the elderly are extremely prone to various types of pain, for many reasons such as an increase in the prevalence of acute and chronic diseases such as stroke, heart disease, type II diabetes and cancer, prompting the pain management medication to request. According to statistics from the United Nations Population Division, in 2019, the total proportion of people over 65 years of age increased from 703 million in 2019 and is expected to reach 1.5 billion by 2050, worldwide.

Market opportunities

Rapid increase in health spending
Health care spending has increased dramatically in the United States over the past few decades. According to the Journal of the American Medical Association (JAMA), health care spending in the United States increased by nearly a trillion dollars between 1996 and 2015. The association said that health spending in the United States in 2017 were around $ 3.5 trillion, i. e, $ 11,000 per person. These expenditures are expected to rise to $ 6 trillion, or about $ 17,000 per person by 2027.

Get the detailed table of contents @

How the Acetaminophen (Paracetamol) Market Report Helps You
In summary, the report provides you with the following knowledge:

  • Revenue forecast to 2031 for Paracetamol market, with predictions for product type, form, and application, each forecast globally and regionally – learn about the industry outlook, finding the most lucrative locations for investment and revenue
  • Revenue forecast to 2031 for 5 regional markets and 16 key national markets – See forecast for the Acetaminophen (Paracetamol) market in North America, Europe, Asia-Pacific and the rest of the world. The market is also expected in the United States, Canada, Argentina, Brazil, Germany, France, United Kingdom, Italy, Spain, China, India, Japan and Australia, among others. significant savings.
  • Outlook for established companies and those looking to enter the market, including company profiles of 10 of the leading companies involved in the Acetaminophen (Paracetamol) Market.

Competitive landscape

The major players operating in the global acetaminophen (paracetamol) market are Aknil biotech, Mallinckrodt, Captab biotech, Farmson, MM Pharma and Genesis Biotech, Granules India, SKPL, Glaxo SmithKline Pharmaceuticals Ltd, Atabay, Arika Healthcare and Sino Chemical.

You will find quantitative and qualitative analyzes with independent predictions. You will receive information that only our report contains, staying informed thanks to this valuable business intelligence.

To access the data contained in this document, please send an email [email protected]

Information found nowhere else
With our survey, you are less likely to fall behind in your knowledge or miss an opportunity. See how you could benefit from your research, analysis and decisions. Also find out how you can save time and be recognized for your business knowledge.

The Visiongain study is aimed at anyone needing business analysis for the Acetaminophen market and leading companies. Here you will find data, trends and forecasts. Please order our report now.

Find more Visiongain research reports at Therapeutic drugs sector click on the following links:

Do you have custom requirements that we can help you with? Do you need specific information about a specific country, geographic region, market segment or company? Contact us today, we can discuss your needs and see how we can help you: [email protected]

About Visiongain

Visiongain is one of the fastest growing and most innovative independent market information, the company publishes hundreds of market research reports which she adds each year to her vast portfolio. These reports provide in-depth analysis of 18 industries around the world. The reports cover a 10-year forecast, are hundreds of pages long, with in-depth market analysis and valuable competitive intelligence data. Visiongain works across a range of verticals, which can currently influence each other, these markets include automotive, aviation, chemicals, cybersecurity, defense, energy, food and beverage, materials, packaging, pharmaceuticals and utilities. Our customized and syndicated market research reports mean you can have tailor-made market information tailored to your business needs.


Sara peerun
Commercial director
Visiongain Inc.
Phone : + 44 207 549 9987
United States Tel: 00 1 718 682 4567
EU Tel: 00 353 1 695 0006
E-mail: [email protected]
The Web:
Follow us: LinkedIn | Twitter

SOURCE Visiongain Limited.

Source link